Literature DB >> 12783156

Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.

Marc R Azar1, Byron C Jones, Gery Schulteis.   

Abstract

RATIONALE: Conditioned place aversion (CPA) is known to be a sensitive measure of the aversive motivational state produced by opioid withdrawal in rats made chronically dependent on opioids.
OBJECTIVE: The purpose of the present study was to examine the sensitivity of the CPA model in detecting a possible aversive state associated with naloxone-precipitated withdrawal from acute treatment with morphine.
METHODS: Doses of morphine and naloxone, as well as number of conditioning trials, were systematically varied to determine the minimum conditions that would result in a detectable CPA in male Wistar rats. Naloxone (0.003-16.7 mg/kg) was administered 4 h after an injection of vehicle or morphine (1.0, 3.3, or 5.6 mg/kg) and immediately prior to confinement to one compartment of the conditioning apparatus; rats received either one or two such naloxone-conditioning trials (separate by 48 h).
RESULTS: Morphine (5.6 mg/kg) followed 4 h later by vehicle produced no significant preference or aversion. In morphine-naive rats, 10 mg/kg naloxone was required to produce a significant CPA with two cycles of conditioning. When increasing doses of morphine were administered (1.0, 3.3, 5.6 mg/kg), significant increases in naloxone potency to elicit a CPA were observed (16-, 211-, and 1018-fold potency shifts, respectively). Naloxone potency after two pretreatments with 5.6 mg/kg morphine was comparable to its potency to elicit a CPA after chronic exposure to morphine. Although naloxone was still effective in producing a CPA after a single conditioning cycle (and hence a single morphine exposure), its effects were dramatically reduced relative to those seen with two conditioning cycles.
CONCLUSIONS: CPA is a reliable and sensitive index of the aversive motivational state accompanying withdrawal from acute opioid dependence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12783156     DOI: 10.1007/s00213-003-1514-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  39 in total

1.  Microinjections of an opiate receptor antagonist into the bed nucleus of the stria terminalis suppress heroin self-administration in dependent rats.

Authors:  J R Walker; S H Ahmed; K N Gracy; G F Koob
Journal:  Brain Res       Date:  2000-01-31       Impact factor: 3.252

2.  Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats.

Authors:  J U Adams; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1990-05       Impact factor: 4.030

3.  Evidence of possible opiate dependence during the behavioral depressant action of a single dose of morphine.

Authors:  D R Meyer; S B Sparber
Journal:  Life Sci       Date:  1977-10-15       Impact factor: 5.037

4.  Aversive properties of naloxone in non-dependent (naive) rats may involve blockade of central beta-endorphin.

Authors:  R F Mucha; M J Millan; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

5.  Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval II.

Authors:  K C Kirby; M L Stitzer; S J Heishman
Journal:  J Pharmacol Exp Ther       Date:  1990-11       Impact factor: 4.030

6.  Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion.

Authors:  J M Delfs; Y Zhu; J P Druhan; G Aston-Jones
Journal:  Nature       Date:  2000-01-27       Impact factor: 49.962

7.  Opioid physical dependence development in humans: effect of time between agonist pretreatments.

Authors:  K C Kirby; M L Stitzer
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Opiate dependence following acute injections of morphine and naloxone: the assessment of various withdrawal signs.

Authors:  R F Ritzmann
Journal:  Pharmacol Biochem Behav       Date:  1981-04       Impact factor: 3.533

9.  Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis.

Authors:  G Schulteis; A Markou; L H Gold; L Stinus; G F Koob
Journal:  J Pharmacol Exp Ther       Date:  1994-12       Impact factor: 4.030

10.  Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning.

Authors:  R F Mucha; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more
  40 in total

1.  Disrupting the memory of places induced by drugs of abuse weakens motivational withdrawal in a context-dependent manner.

Authors:  Stephen M Taubenfeld; Elizaveta V Muravieva; Ana Garcia-Osta; Cristina M Alberini
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

2.  Protracted manifestations of acute dependence after a single morphine exposure.

Authors:  Patrick E Rothwell; Mark J Thomas; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

3.  Chronic CRF1 receptor blockade reduces heroin intake escalation and dependence-induced hyperalgesia.

Authors:  Paula E Park; Joel E Schlosburg; Leandro F Vendruscolo; Gery Schulteis; Scott Edwards; George F Koob
Journal:  Addict Biol       Date:  2013-12-13       Impact factor: 4.280

Review 4.  Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal.

Authors:  Andrew C Harris; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2005-02-05       Impact factor: 4.530

5.  Context- and cue-conditioned potentiation of acute morphine dependence and withdrawal.

Authors:  Gery Schulteis; Jian Liu; Nurith Amitai; Sally Tzeng
Journal:  Pharmacol Biochem Behav       Date:  2005-08-24       Impact factor: 3.533

6.  Effect of glutamate receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats.

Authors:  Yoichi Kawasaki; Chunyu Jin; Katsuya Suemaru; Hiromu Kawasaki; Kazuhiko Shibata; Tominari Choshi; Satoshi Hibino; Yutaka Gomita; Hiroaki Araki
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

7.  Discrete cues paired with naloxone-precipitated withdrawal from acute morphine dependence elicit conditioned withdrawal responses.

Authors:  Nurith Amitai; Jian Liu; Gery Schulteis
Journal:  Behav Pharmacol       Date:  2006-05       Impact factor: 2.293

8.  Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.

Authors:  Gery Schulteis; Andrew C Morse; Jian Liu
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

9.  Reduced emotional signs of opiate withdrawal in rats selectively bred for low (LoS) versus high (HiS) saccharin intake.

Authors:  Anna K Radke; Nathan A Holtz; Jonathan C Gewirtz; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2012-12-20       Impact factor: 4.530

10.  Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access rats.

Authors:  Thomas N Greenwell; Cindy K Funk; Pietro Cottone; Heather N Richardson; Scott A Chen; Kenner C Rice; Eric P Zorrilla; George F Koob
Journal:  Addict Biol       Date:  2009-04       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.